DAFNA Capital Management LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 141 filers reported holding CYTOKINETICS INC in Q4 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$14,127,189
+30.2%
479,538
+44.1%
4.39%
+48.0%
Q2 2023$10,853,783
+11.6%
332,734
+20.3%
2.97%
+1.7%
Q1 2023$9,729,859
+15.4%
276,495
+50.3%
2.92%
+22.9%
Q4 2022$8,430,651
-5.4%
183,9950.0%2.37%
-1.0%
Q3 2022$8,915,000
+7.3%
183,995
-13.0%
2.40%
+5.9%
Q2 2022$8,310,000
+6.7%
211,4950.0%2.26%
+11.6%
Q1 2022$7,785,000
+27.4%
211,495
+57.7%
2.03%
+32.0%
Q4 2021$6,112,000
-2.3%
134,094
-23.4%
1.54%
-7.4%
Q3 2021$6,255,000
+40.8%
175,000
-58.2%
1.66%
+8.8%
Q4 2019$4,443,000
-6.8%
418,7270.0%1.52%
-14.9%
Q3 2019$4,765,000
-11.2%
418,727
-12.3%
1.79%
-11.2%
Q2 2019$5,368,000
+65.8%
477,196
+19.2%
2.02%
+44.5%
Q1 2019$3,238,000
+175.8%
400,294
+115.4%
1.40%
+139.2%
Q4 2018$1,174,000
+90.3%
185,826
+196.4%
0.58%
+130.8%
Q3 2018$617,000
+7.1%
62,690
-9.7%
0.25%
-6.3%
Q2 2018$576,000
-77.5%
69,437
-67.0%
0.27%
-88.0%
Q4 2016$2,555,000
+53.2%
210,306
+15.7%
2.24%
+93.2%
Q3 2016$1,668,000
+17.1%
181,737
+21.2%
1.16%
+2.9%
Q2 2016$1,424,000
+263.3%
150,000
+169.8%
1.13%
+234.0%
Q1 2016$392,000
-6.2%
55,600
+39.0%
0.34%
-9.4%
Q4 2015$418,00040,0000.37%
Other shareholders
CYTOKINETICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
RP Management, LLC 875,656$5,534,0003.79%
BVF INC/IL 4,150,639$26,232,0003.43%
GREAT POINT PARTNERS LLC 3,173,288$20,055,0002.54%
DAFNA Capital Management LLC 185,826$1,174,0000.58%
IRONWOOD INVESTMENT MANAGEMENT LLC 90,783$574,0000.53%
Foresite Capital Management IV, LLC 175,148$1,107,0000.51%
LANSDOWNE PARTNERS (UK) LLP 2,647,981$16,735,0000.25%
WASATCH ADVISORS LP 2,456,805$15,527,0000.21%
PINNACLE ASSOCIATES LTD 592,778$3,746,0000.10%
South Dakota Investment Council 895,316$7,238,0000.08%
View complete list of CYTOKINETICS INC shareholders